EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Advances in the Core Role and Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease

Tianyi Gu, Hangyan Guo, Zixin Guo, Shengyu Hua

Brain and Behavior · 2026

DOI: 10.1002/brb3.71418 ↗

At a glance

Übersichtsarbeit in Brain and Behavior, 2026. Written by Tianyi Gu and 3 co-authors. Institution: College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China. Major MEDLINE topics: Alzheimer Disease, Mitochondria. 178 references. The full text is freely available (open access, CC BY 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Introduction

Alzheimer's disease (AD) is a complex neurodegenerative disorder whose pathogenesis involves multi‐level pathological alterations. This review aims to systematically elucidate the central role and multifaceted molecular mechanisms of mitochondrial dysfunction in the progression of AD.

Methods

A comprehensive analysis of the existing literature was conducted, synthesizing findings from studies investigating mitochondrial involvement in AD pathology. The review focused on key mechanistic pathways, including energy metabolism deficits, oxidative stress, synaptic damage, mitochondrial dynamics, mitochondria‐associated membranes (MAMs), mitophagy, and the gut–brain axis.

Results

The analysis revealed several critical mechanisms linking mitochondrial dysfunction to AD progression: (i) impaired mitochondrial energy metabolism, which establishes a causal relationship with oxidative stress and synaptic injury; (ii) dysregulation of mitochondrial fusion/fission dynamics, particularly the aberrant interactions of amyloid‐beta (Aβ) and p‐Tau with the fission protein Drp1 and the channel protein VDAC1; (iii) dysfunction of mitochondria‐associated membranes (MAMs); (iv) defective mitophagy involving both the PINK1/Parkin pathway and receptor‐mediated pathways; and (v) bidirectional crosstalk between mitochondria and the gut–brain axis. These interconnected pathways converge to amplify neuroinflammation and neuronal death.

Conclusion

Accumulated evidence positions mitochondrial dysfunction as a critical hub that integrates Aβ/Tau pathology, neuroinflammation, and neuronal loss, thereby perpetuating a self‐sustaining vicious cycle in AD. Targeting mitochondrial bioenergetics, dynamics, quality control, and the mitochondria–inflammation axis offers substantial therapeutic promise. Emerging small molecules such as SS31 and DDQ have demonstrated protective effects in preclinical models. Future investigations should prioritize mechanistic dissection and translational research to facilitate the clinical development of mitochondria‐targeted therapies for AD.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseMitochondriaHumansAnimalsMitophagyOxidative StressMitochondrial DynamicsEnergy MetabolismMitochondria Associated MembranesAmyloid beta-PeptidesBrainBrain-Gut Axis

Author keywords

Alzheimer's diseaseinflammationmitochondrial dysfunctionmitophagyneurodegeneration

Substances

Amyloid beta-Peptides

Authors and institutions

  • College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Cite

APA

Gu, T., Guo, H., Guo, Z., & Hua, S. (2026). Advances in the Core Role and Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease. Brain and Behavior. https://doi.org/10.1002/brb3.71418

Vancouver

Gu T, Guo H, Guo Z, Hua S. Advances in the Core Role and Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease. Brain and Behavior. 2026. doi:10.1002/brb3.71418

BibTeX
@article{Gu2026,
  author = {Gu, Tianyi and Guo, Hangyan and Guo, Zixin and Hua, Shengyu},
  title = {Advances in the Core Role and Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease},
  journal = {Brain and Behavior},
  year = {2026},
  doi = {10.1002/brb3.71418}
}
Start for free →